Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
West Bancorporation, Inc. Announces Third Quarter 2024 Financial Results and Declares Quarterly Dividend
-
ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
PLBY Group Rejects Unsolicited Offer for Its Playboy Assets
-
Sidus Space to Present at the 2024 ThinkEquity Conference
-
Inspired to Report Third Quarter 2024 Results on November 7
-
Turtle Beach Corporation to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
-
ConnectM Launches Intelligent AI-Driven Heat Pump Following AHRI Cold Climate Certification
-
Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil
-
Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024
-
Jackery Introduces Solar Generator 5000 Plus – “Most Trusted Whole-Home Backup Power”
-
Ric Flair Drip Partners with Sungrown to Launch in Washington State
-
CleanCore Solutions, Inc. (ZONE) Expands Early Education Vertical with Montessori Schools
-
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024
-
Ozop Energy Solutions, Inc. Selected as National Field Service Partner for Leviton through Ozop Engineering and Design
-
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
-
New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects
-
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
-
Vital Farms to Report Third Quarter 2024 Financial Results on November 7, 2024
-
ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
Ensurge Micropower ASA - Registration of Share Capital Increase
-
PRESS RELEASE: New composition assignment during jubilee for composer & conductor Tijn Wybenga
-
Real Estate Split Corp. Class A Distribution
-
ACNB Corporation Reports 2024 Third Quarter Financial Results
-
Merchize Expands Global Print-On-Demand Services with New Fulfillment Centers and Enhanced E-Commerce Integrations
-
Alliance Witan PLC - Net Asset Value
-
Genius Group Launches GeniusGroup.AI to Power Growth of Genius Cities and AI Education
-
53% of U.S. Tenants Face Housing Affordability Crisis
-
NAPC Defense (OTCPK: BLIS) Awarded in Excess of $1 Million in Clean-up Contracts following Hurricanes Helene and Milton
-
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT plc
-
Wolters Kluwer N.V.: Future Ready Lawyer Survey 2024: Legal professionals confident in managing AI-driven changes to business of law
-
First Merchants Corporation Announces Third Quarter 2024 Earnings per Share
-
Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
-
Carpenter Technology Reports First Quarter Fiscal Year 2025 Results
-
Outbrain to Release Third Quarter 2024 Financial Results on November 7, 2024
-
Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
Dupixent® (dupilumab) Late-Breaking Positive Phase 3 Data in Chronic Spontaneous Urticaria to Be Presented at ACAAI
-
PetMed Express, Inc. Sets Fiscal Second Quarter 2025 Earnings Call
-
Harsco Environmental Secures 10-Year Contract with Nucor Steel Kingman
-
Integer Holdings Corporation Reports Third Quarter 2024 Results
-
Hydrofarm Holdings Group, Inc. to Announce Third Quarter 2024 Results on November 7, 2024
-
Radius Recycling Reports Fourth Quarter and Fiscal 2024 Financial Results
-
Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program
-
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
-
First Watch Restaurant Group, Inc. to Report Third Quarter 2024 Financial Results on November 7, 2024
-
Defined Benefit Pensioners Contribute Billions to Ontario's Economy
-
Payman Khales to assume the role of Integer Chief Operating Officer and Andrew Senn to become President, Cardio & Vascular in the first quarter of 2025
-
BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)
-
DMC Global Schedules Third Quarter Earnings Release and Conference Call
-
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024
